bg
A

Allakos (ALLK)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allakos (ALLK)

Allakos Inc. is a clinical stage biopharmaceutical company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory and proliferative disea... Read more

  • USD1.28
  • USD1.38
  • USD1.20
  • USD3.36
  • 27.80%
  • --
  • 474.46k
  • 320.58k
  • 94M
  • 0.54
  • -54.50%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.